Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Interest Expenses (2016 - 2025)

CorMedix's Interest Expenses history spans 13 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 21898.55% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $2.8 million, up 7927.01%, while the annual FY2025 figure was $2.8 million, 7627.78% up from the prior year.
  • Interest Expenses for Q4 2025 was $1.8 million at CorMedix, up from $948242.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.8 million in Q4 2025 and bottomed at $3585.0 in Q2 2022.
  • The 5-year median for Interest Expenses is $8517.5 (2022), against an average of $179243.2.
  • The largest annual shift saw Interest Expenses plummeted 31.01% in 2021 before it skyrocketed 21898.55% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $5378.0 in 2021, then skyrocketed by 63.16% to $8775.0 in 2022, then rose by 0.01% to $8776.0 in 2023, then fell by 5.88% to $8260.0 in 2024, then surged by 21898.55% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Interest Expenses are $1.8 million (Q4 2025), $948242.0 (Q3 2025), and $6671.0 (Q2 2025).